Diversified Trust CO Iovance Biotherapeutics, Inc. Transaction History

Diversified Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$7.78 - $14.19 $11,428 - $20,845	1,469 Added 9.47%	16,980 $136,000
Q1 2024 Apr 18, 2024	BUY	$7.59 - $17.47 $15,172 - $34,922	1,999 Added 14.79%	15,511 $229,000
Q4 2023 Jan 08, 2024	BUY	$3.3 - $8.89 $4,887 - $13,166	1,481 Added 12.31%	13,512 $109,000
Q3 2023 Nov 17, 2023	BUY	$4.44 - $8.79 $790 - $1,564	178 Added 1.5%	12,031 $54,000
Q2 2023 Jul 18, 2023	BUY	$5.36 - $9.06 $246 - $416	46 Added 0.39%	11,853 $83,000
Q1 2023 Apr 07, 2023	BUY	$5.53 - $8.22 $65,292 - $97,053	11,807 New	11,807 $72,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.